Viewing Study NCT04400851


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-31 @ 8:45 AM
Study NCT ID: NCT04400851
Status: UNKNOWN
Last Update Posted: 2020-09-03
First Post: 2020-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors
Sponsor: Sun Yat-sen University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SunYat-sen-Sintilimab
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View